Alessio Alogna Selected Research

corticosterone acetate

9/2016

Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessio Alogna Research Topics

Disease

10	Heart Failure 01/2022 - 11/2015
3	Cardiogenic Shock 01/2021 - 01/2018
3	Hypertension (High Blood Pressure) 01/2018 - 11/2015
3	Fibrosis (Cirrhosis) 01/2018 - 09/2013
2	Inflammation (Inflammations) 01/2022 - 01/2018
2	Stroke (Strokes) 10/2020 - 10/2019
2	Myocardial Infarction 10/2019 - 01/2018
2	Hypothermia 01/2018 - 03/2016
2	Hypertrophy 01/2018 - 11/2015
1	Sarcopenia 01/2022
1	Obesity 01/2022
1	Myocarditis (Carditis) 01/2022
1	Acute Coronary Syndrome 01/2022
1	Hypovolemia 01/2022
1	Disease Progression 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Infections 01/2022
1	Pericarditis 01/2022
1	Diabetes Mellitus 05/2021
1	Ischemia 01/2021
1	Starvation 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Endotoxemia 10/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Diabetic Cardiomyopathies 01/2018
1	Fever (Fevers) 03/2016
1	Atrial Remodeling 03/2016
1	Hyperthermia 03/2016
1	Hyperlipidemias (Hyperlipidemia) 11/2015
1	Amyloidosis 09/2013

Drug/Important Bio-Agent (IBA)

5	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2018 - 11/2015
2	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 01/2021
2	SodiumIBA 05/2021 - 01/2021
2	Dobutamine FDA LinkGeneric 01/2021 - 03/2016
2	SaltsIBA 09/2016 - 11/2015
1	CytokinesIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	InflammasomesIBA 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	A 19IBA 05/2021
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021
1	IvabradineIBA 01/2021
1	Verapamil (Calan)FDA LinkGeneric 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2019
1	Sevoflurane (Ultane)FDA LinkGeneric 10/2019
1	Neprilysin (Neutral Endopeptidase)IBA 01/2018
1	BAY 41-8543IBA 01/2018
1	Soluble Guanylyl CyclaseIBA 01/2018
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018
1	CollagenIBA 04/2017
1	corticosterone acetateIBA 09/2016
1	AldosteroneIBA 03/2016
1	ConnectinIBA 11/2015
1	Protein Isoforms (Isoforms)IBA 11/2015
1	SugarsIBA 11/2015
1	CholesterolIBA 11/2015
1	Amyloid (Amyloid Fibrils)IBA 09/2013

Therapy/Procedure

2	Catheters 01/2022 - 10/2019
2	Therapeutics 01/2021 - 01/2018
2	Resuscitation 10/2019 - 01/2018
1	Ketogenic Diet 01/2022
1	Lower Body Negative Pressure 01/2022
1	Cardiac Resynchronization Therapy 01/2022
1	Glycemic Control 01/2021
1	Renal Dialysis (Hemodialysis) 01/2021
1	Patient Readmission 01/2021
1	Peritoneal Dialysis 01/2021
1	Heart-Assist Devices 10/2020
1	Extracorporeal Membrane Oxygenation 01/2020
1	Intravenous Infusions 01/2018
1	Induced Hypothermia 03/2016